Clinical trial
Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
NCT00298870 · Osaka University, Other · Completed
Key facts
| NCT number | NCT00298870 |
|---|---|
| Title | Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) |
| Lead sponsor | Osaka University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Tuberculosis |
| Intervention type | Drug |
| Interventions | Isoniazid, isoniazed |
| Enrollment | 172 |
| Start date | Jun 1, 2005 |
| First posted | Mar 3, 2006 |
| Last update posted | Oct 18, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: